Optometrists in Collinsville, OK Accepting Medicare
4 Optometrists found. Showing 1 - 4
 William Martin Grovenburg, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1103 W Center St, Collinsville, OK 74021 Phone: 918-371-3339 |
Dr. Leonard Duane Hart, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1103 W Center St, Collinsville, OK 74021 Phone: 918-371-3339 Fax: 918-371-9600 |
 Collinsville Primary Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 1103 W Center St, Collinsville, OK 74021 Phone: 918-371-3339 |
Primary Eye Care Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1103 W Center St, Collinsville, OK 74021 Phone: 918-371-3339 Fax: 918-371-9600 |
News Archive
More nutrition guidance needed to build good eating habits in growing children, says Nestle FITS survey
Parents and caregivers are hearing and following the feeding guidance for infants, yet continued work needs to be done to help them also build good eating habits for their growing children, suggests data from the Nestle Feeding Infants and Toddlers Study (FITS) released today at a symposium at the American Dietetic Association's Food & Nutrition Conference & Expo.
Decision Resources: Only 52.2% of first-line Alzheimer's disease patients prescribed AChEI
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while approximately 70 percent of surveyed physicians' newly diagnosed patients have mild-to-moderate Alzheimer's disease, only 52.2 percent of first-line patients are prescribed an acetylcholinesterase inhibitor.
VIVUS presents additional data on Qnexa Phase 3 trials
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Varian enters accelerated share repurchase agreement
Varian Medical Systems today announced that it has entered into an agreement with Bank of America, N.A. to repurchase $250 million of its common stock under an accelerated share repurchase program. Concurrently, the company amended its revolving credit facility with Bank of America, N.A. to increase its borrowing capacity from $225 million to $300 million.
› Verified 5 days ago
Optometrists
Physical Therapists
Occupational Therapists
Chiropractors